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Abstract
Aims: Although N-acetylcysteine (NAC) can decrease reactive oxygen species and improve myocardial recovery after
ischemia/hypoxia in various acute animal models, little is known regarding its long-term effect in neonatal subjects. We
investigated whether NAC provides prolonged protective effect on hemodynamics and oxidative stress using a surviving
swine model of neonatal asphyxia.
Methods and Results: Newborn piglets were anesthetized and acutely instrumented for measurement of systemic
hemodynamics and oxygen transport. Animals were block-randomized into a sham-operated group (without hypoxia-
reoxygenation [H–R, n=6]) and two H-R groups (2 h normocapnic alveolar hypoxia followed by 48 h reoxygenation, n=8/
group). All piglets were acidotic and in cardiogenic shock after hypoxia. At 5 min after reoxygenation, piglets were given
either saline or NAC (intravenous 150 mg/kg bolus + 20 mg/kg/h infusion) via for 24 h in a blinded, randomized fashion.
Both cardiac index and stroke volume of H-R controls remained lower than the pre-hypoxic values throughout recovery.
Treating the piglets with NAC significantly improved cardiac index, stroke volume and systemic oxygen delivery to levels
not different from those of sham-operated piglets. Accompanied with the hemodynamic improvement, NAC-treated piglets
had significantly lower plasma cardiac troponin-I, myocardial lipid hydroperoxides, activated caspase-3 and lactate levels (vs.
H-R controls). The change in cardiac index after H-R correlated with myocardial lipid hydroperoxides, caspase-3 and lactate
levels (all p,0.05).
Conclusions: Post-resuscitation administration of NAC reduces myocardial oxidative stress and caused a prolonged
improvement in cardiac function and in newborn piglets with H-R insults.
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Introduction
There are reports showing cardiovascular dysfunction occurs in
29–67% of asphyxiated neonates using different diagnostic criteria
and methods [1,2,3]. The outcome of asphyxiated neonates with
severe cardiovascular dysfunction is poor and more cardiac
support was required during the recovery in these cases [4,5].
The overproduction of reactive oxygen and nitrogen species
during the reperfusion/reoxygenation after hypoxic-ischemic
insult will lead to a second strike to myocardial tissues [6,7]. It is
therefore expected that treating the patients suffering from
hypoxic-reoxygenation (H–R)/ischemic-reperfusion (I–R) events
with antioxidants would minimize the cardiac injury induced by
reactive oxygen species (ROS) through various mechanisms
[8,9,10]. Indeed, the cardiac protective effects of antioxidants
have been confirmed in numerous studies of hypoxia-reoxygena-
tion injury [11,12]. N-Acetylcysteine has been shown to protect
various organs against injury after I–R or H–R [13,14]. Other
than acting as a ROS scavenger, NAC is a precursor of L-cysteine
and reduced glutathione [15]. It releases thione and converts
glutathione into reduced form of GSH which is exhausted during
hypoxia and ischemia [16]. Moreover, NAC has been shown to
prevent H–R or I–R induced injury via both apoptotic and
inflammatory pathways which include the inhibition of NF-kappa
B expression as well as caspase-3 activity [17,18].
Previously in an acute piglet model of neonatal asphyxia, we
showed that intravenous infusion of NAC improved cardiac
output, stroke volume and systemic oxygen delivery without any
changes in mean arterial pressure (MAP) and heart rate [9].
Its beneficial effects might be related to the prompt replenishment
of reduced glutathione, scavenging tissue hydrogen peroxide
[19] and decreasing lipid hydroperoxides [20]. However, the
cardioprotective effect of NAC needs to be further studied at a
later stage after resuscitation since the asphyxiating event also has
prolonged effects on cardiac function [21]. Abnormal electrocar-
diography, poor left ventricular function, elevated plasma
concentrations of creatinine kinase and cardiac troponins have
been observed in asphyxiated neonates at 24–72 h after birth
[21,22,23]. Similarly, plasma troponin I of neonates with cardiac
dysfunction remains elevated at more than 72 h after birth [24].
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asphyxiated neonates persists more than 24 h after I–R or H–R
insults. Although NAC has been shown to have prolonged cardiac
protective effect in various adult animal models [25,26], limited
studies have been carried out to examine its prolonged effect in
neonates whose anti-oxidant system is compromised especially
with asphyxia.
Using a surviving swine model of neonatal asphyxia, we
investigated the effects of NAC on cardiac function as well as its
underlying mechanisms after H–R. We hypothesized that the post-
resuscitation administration of NAC in asphyxiated newborn
piglets would improve the systemic haemodynamics and oxygen
transport with the attenuation of oxidative stress in the
myocardium.
Methods
All experiments were conducted in accordance with the
guidelines of Canadian Council of Animal Care (2001) and
approved by the Animal Care and Use Committee: Health
Sciences, University of Alberta (ACUC: HS Protocol #238/06/
10D). Male newborn Yorkshire-Landrace piglets 1 day of age
weighing 1.6 to 2.5 kg (mean body weight = 1.9360.04 kg) were
used.
Anaesthesia
The animal preparation was similar to that described previously
[9]. Briefly, anesthesia was initially maintained with inhaled
isoflurane (2–3%), which was then switched with fentanyl (0.005–
0.05 mg/kg/h), midazolam (0.1–0.2 mg/kg/h) and pancuronium
(0.05–0.1 mg/kg/h) once mechanical ventilation was commenced.
Oxygen saturation was continuously monitored with a pulse
oximeter (Nellcor, Hayward, CA), and heart rate and blood
pressure were measured with a 78833B monitor (Hewlett Packard
Co., Palo Alto, CA). Fractional inspired oxygen concentration
(FiO2) was measured by an oxygen monitor (Ohmeda Medical,
Laurel, MD) and maintained at 0.21–0.24 for oxygen saturation
between 90 and 97%. Maintenance fluids during experimentation
consisted of 5% dextrose at 10 ml/kg/h and 0.9% normal saline
solution at 2 ml/kg/h. The body temperature was maintained at
38.5–39.5uC using an overhead warmer and a heating pad.
Surgical preparation
Argyle catheters (5F; Sherwood Medical Co., St. Louis, MO)
were inserted via the right femoral artery and vein for continuous
measurement of MAP and central venous pressure, respectively.
All medications and fluids were administered via the femoral
venous catheter. Via a tracheotomy, pressure-controlled assisted
ventilation was commenced (Model IV-100, Sechrist Industries
Inc., Anaheim, CA) with pressure of 20/4 cm H2O at a rate of
18–20 breaths/min. A left anterior thoracotomy was performed to
expose the main pulmonary artery. A 20G Insyte-W
TM catheter
(Becton Dickinson Infusion Therapy Systems Inc., Sandy, UT)
was inserted into the root of the main pulmonary artery for the
measurement of mean pulmonary artery pressure (PAP) and
mixed venous blood oxygen saturation. A 6-mm transit time
ultrasound flow probe (6SB, Transonic Systems Inc., Ithaca, NY)
was placed around the main pulmonary artery to measure the
blood flow as a surrogate of cardiac output.
Experimental protocol (Fig. 1)
After surgery, animals were stabilized for at least 60 min. Piglets
were block-randomized into a sham-operated group (without H–
R, but was ventilated with FiO2 of 0.21 throughout the
experimental period, n=6) or two H–R experimental groups
(n=8 each) with 2 h hypoxia induced by decreasing the FiO2 to
0.10–0.13 using nitrogen and oxygen gas mixture to achieve severe
hypoxemia (partial pressure of oxygen [PaO2] 20–40 mmHg) for
2 h. After hypoxia, piglets were resuscitated with a FiO2 of 1.0 for
1 h, followed by 0.21 for the reminder of the experimental period.
Five minutes after reoxygenation, piglets were received either
saline (H–R control, 3 ml/kg bolus + 2 ml/kg/h infusion, i.v.) or
NAC (150 mg/kg bolus + 20 mg/kg/h, i.v) for 24 h in a blinded,
randomized fashion. The dosage and regimen of NAC was based
on the clinical protocol used for acetaminophen overdose and our
previous studies [9,19]. During the 48 h of observation, the piglet
was placed under a radiator and continuously cared by two
experienced team members (JQL and TFL) alternatively who did
not know the randomization. Peak inspiratory pressure (18–25 cm
H2O) and respiratory rate (12–20 breaths/min) were adjusted to
maintain normocapnia. The dosages of fentanyl, midazolam and
pancuronium were adjusted to maintain minimum body move-
ments throughout the experimental period. Propofol (0.1–0.2 mg/
kg/h) was given as needed to maintain anesthesia. A gastric tube
was inserted into the stomach orally and drained if needed. A 20G
Insyte-W angiocatheter was inserted into bladder transcutaneously
to drain the urine. Blood gases were studied every 30 min during
hypoxia and 100% oxygen of reoxygenation, every 4 h within first
24 h and every 6 h within second 24 h. At the end of the
experiment, the piglet was euthanized with an overdose of
pentobarbital (100 mg/kg, i.v.). Left ventricle was removed rapidly
and flash-frozen in liquid nitrogen and stored at -80uC for
subsequent analysis.
Hemodynamic recordings and calculations
Hemodynamic parameters (heart rate, MAP, central venous
pressure and pulmonary artery flow) were recorded at specific
predetermined time points at baseline throughout hypoxia and
reoxygenation. Cardiac index (CI), a surrogate estimated by
the pulmonary artery flow because of the existence of patent
ductus arteriosus, was corrected for individual piglet mass. Stroke
volume index, oxygen content, systemic oxygen delivery, con-
sumption and oxygen extraction ratio were calculated using
Figure 1. Experimental protocol.
doi:10.1371/journal.pone.0015322.g001
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Stroke volume index ml=kg=beat ðÞ ~ CI 7 Heart rate
Systemic oxygen delivery ml O2=kg=min ðÞ ~
CI | SaO2| 1:36 | Hgb ½ 
Systemic oxygen consumption mlO2=kg=min ðÞ ~
CI | SaO2{ SvO2 ðÞ | 1:36 | Hgb ½ 
Systemic oxygen extraction ratio % ðÞ ~
SaO2{ SvO2 ðÞ = SaO2 ½  | 100%
Biochemical analysis
Myocardial tissues were homogenized with 10 ml/mg of 50 mM
phosphate buffer containing 1 mM EDTA (pH 7.0). The tissue
levels of oxidized and total glutathione (GSSG and GSH,
respectively), lipid hydroperoxides (LPO) and activated caspase-3
were measured using commercially available assay kits (#703002,
#705002, #10009135, respectively, Cayman Chemical, Ann
Arbor, MI). Tissue lactate was assayed by enzymatic spectrometric
methods. Plasma cTnI concentration was measured using a
commercially available ELISA kit (#2010-4-HS, Life Diagnostics,
West Chester, PA). The protein content was determined by
bicinchoninic acid assay kit (Sigma-Aldrich Canada Ltd., Oakville,
ON).
Statistical analysis
All results were expressed as mean6SEM. One- and two-way
analysis of variance (ANOVA) tests were used to study the
differences among groups as appropriate. Post-hoc testing with
Tukey Method was performed for pairwise comparisons with the
H–R control group. Non-parametric parameters of cardiac
Troponin I were analyzed using ANOVA on rank and Dunn’s
tests for multiple comparisons. Correlation between variables was
studied by Pearson Moment test. Statistical analyses were
performed using SigmaStatH (V. 2.0, Jandel Co.). Significance
was set at p,0.05.
Results
There were no differences in body weight, age, hemodynamic
and blood gases parameters at baseline among experimental
groups.
Effect of NAC treatment on arterial blood gas and acid-
base status
Metabolic acidosis developed after 2 h of normocapnic alveolar
hypoxia (Table 1). Upon reoxygenation, PaO2, pH and base
excess levels of piglets recovered gradually towards the respective
normoxic baseline values and were not significantly different from
those of sham-operated piglets at the end of experiment. Treating
the animals with NAC did not cause any significant changes in
blood gas and acid-base status during reoxygenation recovery
(Table 1).
Table 1. Changes in arterial blood gas during hypoxia and reoxygenation.
Baseline End of hypoxia Reoxygenation (hours)
1 4 8 1 62 44 8
pH
Sham 7.4760.02 7.4560.02* 7.4760.02* 7.4560.02 7.4660.01 7.4560.01 7.4460.02 7.4560.02
Control 7.4760.02 7.0560.02 7.3360.02 7.4560.02 7.4560.02 7.3960.02 7.3760.02 7.3960.04
NAC 7.4860.02 7.0460.02 7.3360.03 7.4660.02 7.4960.02 7.4660.02 7.4160.01 7.4760.01
PaCO2 (mmHg)
Sham 35623 9 613 8 613 9 613 8 613 7 623 8 623 8 61
Control 35624 2 633 6 623 7 613 6 624 4 624 5 624 3 62
NAC 34614 1 623 6 613 7 623 7 613 9 624 1 623 7 61
PaO2 (mmHg)
Sham 65626 2 61* 6062* 60626 2 635 9 626 2 626 4 62
Control 64623 0 623 4 6 626 65635 9 636 2 636 2 635 9 67
NAC 70623 5 653 6 7 621 59615 7 626 0 626 2 636 1 63
Arterial O2 saturation (%)
Sham 9561.0 9460.6* 9360.8* 9360.9 9360.5 9360.7 9360.8 9361.4
Control 9561.0 3161.4 10060.3 9460.7 9261.3 9261.0 9261.4 9161.6
NAC 9560.6 3063.1 10060.2 9260.6 9461.5 9361.0 9361.4 9461.0
Base Excess (mmol/L)
Sham 2.661.3 3.361.3* 3.261.2* 2.761.0 2.761.0 2.960.7 3.060.8 2.660.6
Control 2.560.7 218.460.7 26.360.7 2.160.9 2.860.5 2.160.7 2.260.8 2.160.7
NAC 2.660.8 218.660.9 25.061.2 3.160.8 4.360.7 3.360.8 2.860.6 2.661.1
*Significantly different from the H2R control group (p,0.05).
doi:10.1371/journal.pone.0015322.t001
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Of H2R control piglets, CI decreased significantly at the end of
hypoxia and rebound immediately upon resuscitation (Fig. 2A).
Thereafter, CI gradually deteriorated and was lower than the
baseline value throughout the first 12 h of reoxygenation period
(p,0.05). NAC-treated piglets had CI higher than the baseline
value initially, which was maintained at the baseline value
throughout the reoxygenation period. Overall, CI of NAC-treated
piglets was significantly higher than that of H2R control piglets
throughout the reoxygenation period (Fig. 2A).
Heart rate increased significantly in hypoxic piglets (Fig. 2B). At
1 h of reoxygenation, heart rate of NAC-treated group was higher
than that of both H2R control and sham-operated groups (22467
vs. 19868 and 19165 beats/min, respectively; p,0.05). Howev-
er, there were no statistical differences among all experimental
groups thereafter (Fig. 2B).
The pattern of changes in stroke volume index corresponded to
that observed with CI (Fig. 2C). The stroke volume index of H2R
control piglets was significantly lower than that of sham-operated
groups during the reoxygenation period.
MAP decreased to 45% of the normoxic baseline value after 2 h of
hypoxia (p,0.05)(Fig. 3A). The MAP of H2R controls rose
immediately after reoxygenation but then gradually fell and remained
lower than the baseline value throughout the recovery
(p,0.05)(Fig. 3A). The MAP of NAC-treated piglets increased 12 h
after reoxygenation and was the about the same level as the sham-
operated group afterward (Fig. 3A). The PAP of hypoxic piglets was
significantly higher than the normoxic baseline value at 2 h of hypoxia
and remained elevated during the first 15 min of reoxygenation
(Fig. 3B). The PAP then normalized at 1 h of reoxygenation with no
difference among groups (Fig. 3B). The PAP/MAP ratio of H2R
controls was higher than that of sham-operated and NAC-treated
groups throughout the reoxygenation period (p,0.05)(Fig. 3C).
Effects of NAC treatment on systemic oxygen transport
Systemic oxygen delivery was significantly decreased in hypoxic
piglets at 2 h of hypoxia, and rebounded to the level of sham-
operated after reoxygenation with 100% O2 (Fig. 4A). The oxygen
delivery of NAC-treated animals was higher than that of H2R
controls (p,0.05), and returned to a level similar to that of the
sham-operated group after switching to room-air. The oxygen
delivery of H2R control group was low throughout the recovery,
but was not significantly different from the other two groups.
Systemic oxygen consumptionof H2R controls increased gradually
after reoxygenation but remained significantly lower than baseline
value throughout the reoxygenation period (p,0.05)(Fig. 4B). NAC
treatment improved systemic oxygen consumption to baseline value
at 4 h after reoxygenation, and maintained the same level as sham-
operated group throughout the observation period (Fig. 4B). The
systemic oxygen consumption of NAC-treated piglets was signifi-
cantly higher than that of H2R controls. Corresponding to the
better oxygen delivery after reoxygenated with 100% O2 in NAC-
treated animals, the systemic oxygen extraction was lower than that
of H2R controls. The systemic oxygen extraction returned to the
level of sham-operated in both H2R groups after reoxygenated
with room-air and maintained at a level similar to that of sham-
operated piglets thereafter (Fig. 4C).
Effects of NAC on various biochemical and oxidative
stress markers in myocardial tissues
Following H2R, the myocardial contents of total glutathione,
GSSG and glutathione redox ratio (GSSG:GSH) on left ventricle
of the H2R controls was not different from those of the sham-
operated group (Table 2). Myocardial total glutathione, but not
GSSG and redox ratio, was increased in NAC-treated animals
(Table 2).
The myocardial LPO accumulation of H2R control piglets was
significantly higher than those of sham-operated piglets, and the
LPO accumulation was significantly reduced by NAC treatment
(Table 2). Similarly, the increased activity of myocardial caspase-3
of H2R controls (vs. sham-operated piglets, p,0.05) was
significantly reduced by NAC treatment (Table 2). The myocardial
caspase-3 activities correlated positively with LPO accumulation
(r=0.53, p,0.05).
The myocardial lactate content of control piglets was higher
than that of sham-operated group (p,0.05), whereas NAC
significantly reduced the myocardial lactate content (Table 2).
Interestingly, the lactate content was positively correlated with
LPO accumulation and caspase-3 activity (r=0.42, p,0.05 and
r=0.67, p,0.001; respectively). Furthermore, the change in CI
after H2R (area under the curve) was negatively correlated with
myocardial LPO, caspase-3 and lactate (r=20.47, 20.56 and
20.47; all p,0.05, respectively).
Effect of NAC on plasma cardiac troponin-I and lactate
production
The plasma cTnI concentration of sham-operated piglets did
not change during the experimental period (Fig. 5A). Plasma cTnI
of H2R controls increased gradually and was significantly higher
than the sham-operated group throughout the reoxygenation
period (Fig. 5A). As compared with H2R controls, animals treated
with NAC gradually decreased the cTnI concentration and was
significantly lowered at the end of the experiment (Fig. 5A).
Although plasma lactate concentrations of the H2R control
group were slightly higher than both sham-operated and NAC-
treated groups throughout the experimental period, the difference
was not significant (Fig. 5B).
Discussion
We hereby observed that post-resuscitation NAC infusion
significantly improved the overall cardiac performance, particu-
larly at the early phase of reoxygenation, consequently normalized
the systemic oxygen delivery of H2R newborn piglets throughout
reoxygenation. NAC treatments also attenuated myocardial LPO
accumulation, caspase-3 activity as well as lactate content, and
reduced the plasma cTnI concentration by the end of reoxygena-
tion period.
The cardiac dysfunction after resuscitation contributes to the
mortality and morbidity of neonates with perinatal asphyxia
[21,23]. Depending on the diagnostic criteria, cardiac dysfunction
was observed in 29267% of asphyxiated neonates [1,2,3]. Cardiac
function can remain diminished with poor cardiac output and
hypotension in the first 24248 h after birth [27], similar to what
we observed in our model of neonatal asphyxia. Using state-of-the-
art technique such as functional echocardiography to determine
cardiac function will be extremely revealing and useful. Nonethe-
less, as the result of poor systemic perfusion or delayed recovery
from asphyxia, about 60% these cases were associated with
adverse neurological outcome [2]. Thus, maintaining cardiac
function after resuscitation may help to minimize further injury to
asphyxiated neonates. As indicated by the lower CI and overall
oxygen delivery, cardiac dysfunction did occur in H2R controls
during reoxygenation.
In contrast to the cardiac dysfunction observed in H2R
controls, treating the piglets with NAC significantly improved both
Cardiac Recovery of NAC-Treated Newborn Pigs
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15322Figure 2. Effects of NAC on cardiac performance. Temporal changes in (A) cardiac index, (B) heart rate and (C) stroke volume index in sham-
operated piglets (#, without hypoxia and reoxygenation, n=6), hypoxia piglets receiving either saline (N,H 2R control, n=8) or NAC (m,n=8 )a t
5 min after reoxygenation. *p,0.05 vs. H2R control group at corresponding time point,
{p,0.05 vs. H2R controls during reoxygenation period (2-
way repeated measures ANOVA).
doi:10.1371/journal.pone.0015322.g002
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15322Figure 3. Effects of NAC on blood pressure. Temporal changes in (A) mean arterial pressure (MAP), (B) pulmonary artery pressure (PAP) and
(C) PAP/MAP ratio in sham-operated piglets (#, without hypoxia and reoxygenation, n=6), hypoxia piglets receiving either saline (N,H 2R control,
n=8) or NAC (m, n=8) at 5 min after reoxygenation. *p,0.05 vs. H2R control group at corresponding time point,
{p,0.05 vs. H2R controls during
reoxygenation period (2-way repeated measures ANOVA).
doi:10.1371/journal.pone.0015322.g003
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PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15322Figure 4. Effects of NAC on systemic oxygen delivery and extraction. Temporal changes in (A) systemic oxygen delivery (sys-DO2), (B)
systemic oxygen consumption (sys-VO2) and (C) systemic oxygen extraction (sys-EO2) in sham-operated piglets (#, without hypoxia and
reoxygenation, n=6), hypoxia piglets receiving either saline (N,H 2R control, n=8) or NAC (m, n=8) at 5 min after reoxygenation. *p,0.05 vs. H2R
control group at corresponding time point,
{p,0.05 vs. H2R controls during reoxygenation period (2-way repeated measures ANOVA).
doi:10.1371/journal.pone.0015322.g004
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Plasma cTnI is a sensitive and specific marker of myocardial injury
used for the diagnosis and prediction of the myocardial
impairment [3,23]. Similarly to those reported in adult patients
with myocardial ischemia [28,29], the plasma cTnI level of H2R
controls peaked at 12 h after hypoxia and maintained high during
the reoxygenation period. NAC treatment significantly decreased
H2R-induced elevated cTnI concentration at the end of
experimental period, indicating attenuated myocardial injury. Of
note, this was associated with the significant reduction in
myocardial lactate content, which was negatively correlated with
CI. Interestingly, Harrison et al suggested that the increase in
oxygen delivery could account for the beneficial effect of NAC in
patients with fulminant hepatic failure [30]. Taken together, our
results demonstrated that NAC could elicit a prolonged improve-
ment in cardiac recovery in newborn asphyxiated piglets.
NAC is a precursor of L-cysteine and reduced glutathione [15].
It releases thione and converts glutathione into reduced form of
GSH which is exhausted during hypoxia and ischemia [16].
Similarly to that reported previously in our acute study [9], a
significant increase in myocardial GSH, but not GSSG and redox
ratio, was observed in piglets receiving NAC treatment. Although
the myocardial contents and redox ratio of glutathione were
similar in H2R control and sham-operated group at the end of
the experiment (48 h), the apparent contradiction could be due the
fact that the endogenous glutathione system may have been
restored during the prolonged recovery period. Furthermore, in
addition to direct conversion from NAC, the increase in GSH in
NAC-treated piglets may also be due to increased GSSH-
reductase activity. Interestingly, oxidative stress has been shown
to stimulate pentose-phosphate pathway that generates NADPH, a
necessary cofactor for GSSH-reductase to maintain cellular GSH
[31,32]. As it has been shown previously that myocardial injury
can be minimized by enhancing the glutathione content [33,34],
we speculate that replenishing endogenous GSH may, at least in
part, account for the beneficial effect of NAC in improving cardiac
recovery.
Associated with the impaired cardiac function, increases in
myocardial LPO and caspase-3 were observed in H2R controls.
Interestingly, the negative correlation between CI with both LPO
accumulation and caspase-3 activity in the left ventricle may
reflect the involvement of ROS in its pathogenesis. Indeed, the
correlation between oxygen concentrations used in neonatal
resuscitation and myocardial injury has been demonstrated [35].
ROS formed during oxidative stress can initiate lipid peroxidation,
oxidize proteins and cause apoptosis cascades, all potentially
damaging to normal cellular function. Complementary to our
findings, reduced cardiac function has been observed in hearts
perfused with various ROS generating systems [36,37]. Therefore,
these findings indicate that cardiac dysfunction in hypoxic
newborn piglets observed after reoxygenation is associated with
ROS-induced oxidative stress. Treating H2R piglets with NAC
Table 2. Effects of NAC on myocardial contents of glutathione, lipid hydroperoxides (LPO), caspase-3 and lactate levels after
hypoxic-reoxygenation.
Tissue content Sham-operated H-R Control NAC p value (ANOVA)
Glutathione (nmol/mg protein)
GSH 399.6636.8 352.0616.5 441.568.4* 0.047
GSSG 8.8761.3 8.1661.6 13.761.9 0.054
GSSG/GSH 0.0260.003 0.0260.004 0.0360.004 0.372
LPO (nmol/mg protein) 9.4262.4* 28.164.8 16.762.7* 0.007
Caspase-3 (Unit/mg protein) 0.3160.1* 0.7160.1 0.4260.1* 0.002
Lactate (mmol/mg protein) 2.7160.2* 5.9260.4 2.9660.1* 0.016
*p,0.05 vs. H2R controls.
doi:10.1371/journal.pone.0015322.t002
Figure 5. Effects of NAC on plasma troponin I and lactate.
Changes in plasma (A) cardiac troponin I and (B) lactate concentrations
in sham-operated (n=6), H2R control (n=8) and NAC-treated (n=8)
piglets at 4 h, 12 h, and 48 h after reoxygenation. *p,0.05 vs. H2R
control group at corresponding time point.
doi:10.1371/journal.pone.0015322.g005
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LPO. This observation is consistent with the previous report
showing that NAC can reduce ROS generation by its direct
scavenging action [19,38]. Interestingly, NAC has also been
reported to attenuate the I2R-induced increase in peroxynitrite, a
potent oxidant for tissue protein and lipid oxidation and
detrimental effects on myocardial function [39,40].
Similarly to previous reports of H2Ro rI 2R [41,42], increased
caspase-3 activities were observed in the left ventricular myocar-
dial tissue obtained from our H2R piglets. Caspases, particularly
caspase-3, are involved in the apoptotic process [43,44]. By using
caspase inhibitor at different stages, it has been shown that only
those caspases activated during reoxygenation were responsible for
H2R induced apoptosis [45]. Reducing myocardial caspase-3
activity by various pharmacological therapies has been shown to
minimize myocardial infarct size as well as myocardial injury
[41,42]. Previous studies have demonstrated that NAC could
prevent apoptotic death of neuronal cell in vitro [46,47]. We found
that post-resuscitation treatment with NAC significantly reduced
the activated caspase-3 levels after H2R. Interestingly, it is
documented that cytochrome C released from mitochondria under
oxidative stress can participate in the formation of apoptosome,
the caspase-activating complex [48]. Regardless of the underlying
mechanism, we demonstrated that the change in CI after H2R
was negatively correlated with myocardial caspase-3 activity.
Thus, our results suggest that caspase-3 may play an essential role
in the worsening of cardiac function after H2R. NAC treatment
may attenuate the apoptotic process through a reduction of ROS
accumulation. This speculation is further supported by the positive
correlation between myocardial activated caspase-3 and LPO.
Of note, NAC has been attempted without significant benefit in
neonates at risk for bronchopulmonary dysplasia [49]. While the
organ selectivity of NAC-induced protection remains to be
investigated, in this setting of acute injury of H2R, we speculate
the prolonged protective effects of NAC may be related to its anti-
oxidative and anti-apoptotic effects in preventing myocardial
injury. There were some limitations in this study. Firstly,
asphyxiated neonates commonly have reduction of cardiac output
[17], or stroke volume [50] within 24 h after birth, and require
inotropic support. In this model, although CI and stroke volume of
hypoxic piglets decreased to approximately 50% of the baseline at
2 h of hypoxia with acidemia similar to that of asphyxiated
neonates in the delivery room (pH,7.1, HCO3,12 mmol/L),
this does not replicate the exact situation in clinical scenario.
Secondly, in order to minimize the effects of CO2 on the
hemodynamic changes and cardiac function, normocapnia of the
animals in this study was maintained during the experiment, while
asphyxiated neonates usually have hypercapnia and ventilation is
required. Thirdly, mechanisms of the relationship between NAC-
improved cardiac function and the reduction of elevated levels of
tissue lactate, LPO and caspase-3 in the myocardial tissue of left
ventricle need to be further investigated. Furthermore, although
the dosage of NAC was based on our previous studies of acute
experimentation and has also been shown to be safe for neonates,
the information of L-cysteine levels and dose-response of NAC
treatment will be important in the translation of our findings to
clinical setting. Despite reduced mortality has been seen in the
resuscitation of asphyxiated term neonates with room air,
compared to those with 100% oxygen, neonatal resuscitation with
100% oxygen remains a common practice in many centers,
especially in community hospitals before the arrival of transport
team. Recently, the guideline on the use of supplementary oxygen
during neonatal resuscitation has been revised and it is
recommended to start with 21% oxygen [51]. The cardiac
protective effects of NAC when 21% oxygen is used during
resuscitation will be interesting. Finally, it is interesting to further
examine the role of anti-oxidants during neonatal resuscitation
while we studied a state of excessive oxidative stress and its related
injury, which is not uncommon in clinical conditions including
uncontrolled hyperoxic resuscitation of asphyxiated neonates,
cardio-pulmonary bypass and veno-arterial extracorporeal mem-
brane oxygenation.
Conclusions
In summary, post-resuscitation administration of NAC results in
prolonged improvement in cardiac function and systemic oxygen
delivery in asphyxiated newborn piglets 48 hours after H-R insult.
Although our results demonstrate that NAC can also reduce LPO
accumulation and caspase-3 activity, the exact mechanism on
reducing oxidative stress still remains to be elucidated.
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